CORCEPT THERAPEUTICS INC (1CORT.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1CORT - US2183521028 - Common Stock
62.7 EUR
+62.7 (+Infinity%)
1CORT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 53 industry peers in the Pharmaceuticals industry. Both the health and profitability get an excellent rating, making 1CORT a very profitable company, without any liquidiy or solvency issues. 1CORT is valued quite expensively, but it does show have an excellent growth rating. These ratings would make 1CORT suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
1CORT had positive earnings in the past year.
1CORT had a positive operating cash flow in the past year.
1CORT had positive earnings in each of the past 5 years.
1CORT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1CORT has a better Return On Assets (15.83%) than 92.16% of its industry peers.
Looking at the Return On Equity, with a value of 19.61%, 1CORT is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
With a decent Return On Invested Capital value of 13.61%, 1CORT is doing good in the industry, outperforming 76.47% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1CORT is above the industry average of 13.94%.
The last Return On Invested Capital (13.61%) for 1CORT is well below the 3 year average (17.94%), which needs to be investigated, but indicates that 1CORT had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.83% | ||
| ROE | 19.61% | ||
| ROIC | 13.61% |
ROA(3y)17.09%
ROA(5y)19.27%
ROE(3y)20.64%
ROE(5y)22.43%
ROIC(3y)17.94%
ROIC(5y)20.7%
1.3 Margins
1CORT has a better Profit Margin (19.55%) than 80.39% of its industry peers.
1CORT's Profit Margin has declined in the last couple of years.
1CORT's Operating Margin of 16.17% is in line compared to the rest of the industry. 1CORT outperforms 47.06% of its industry peers.
In the last couple of years the Operating Margin of 1CORT has declined.
With an excellent Gross Margin value of 98.43%, 1CORT belongs to the best of the industry, outperforming 96.08% of the companies in the same industry.
1CORT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.17% | ||
| PM (TTM) | 19.55% | ||
| GM | 98.43% |
OM growth 3Y-15.83%
OM growth 5Y-11.04%
PM growth 3Y-12.04%
PM growth 5Y-7.41%
GM growth 3Y-0.06%
GM growth 5Y0.04%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1CORT is creating value.
Compared to 1 year ago, 1CORT has more shares outstanding
1CORT has less shares outstanding than it did 5 years ago.
1CORT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 31.21 indicates that 1CORT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 31.21, 1CORT belongs to the top of the industry, outperforming 98.04% of the companies in the same industry.
1CORT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 31.21 |
ROIC/WACC1.4
WACC9.75%
2.3 Liquidity
1CORT has a Current Ratio of 3.07. This indicates that 1CORT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of 1CORT (3.07) is better than 92.16% of its industry peers.
1CORT has a Quick Ratio of 2.96. This indicates that 1CORT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.96, 1CORT belongs to the best of the industry, outperforming 92.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.43% over the past year.
1CORT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.71% yearly.
The Revenue has grown by 30.93% in the past year. This is a very strong growth!
Measured over the past years, 1CORT shows a quite strong growth in Revenue. The Revenue has been growing by 17.11% on average per year.
EPS 1Y (TTM)9.43%
EPS 3Y11.69%
EPS 5Y9.71%
EPS Q2Q%-32%
Revenue 1Y (TTM)30.93%
Revenue growth 3Y22.64%
Revenue growth 5Y17.11%
Sales Q2Q%7.09%
3.2 Future
The Earnings Per Share is expected to grow by 56.00% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 30.41% on average over the next years. This is a very strong growth
EPS Next Y13.31%
EPS Next 2Y47.92%
EPS Next 3Y70.13%
EPS Next 5Y56%
Revenue Next Year29.78%
Revenue Next 2Y32.48%
Revenue Next 3Y32.46%
Revenue Next 5Y30.41%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 63.33 indicates a quite expensive valuation of 1CORT.
1CORT's Price/Earnings ratio is a bit more expensive when compared to the industry. 1CORT is more expensive than 64.71% of the companies in the same industry.
1CORT is valuated expensively when we compare the Price/Earnings ratio to 26.26, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 27.05, which means the current valuation is very expensive for 1CORT.
Based on the Price/Forward Earnings ratio, 1CORT is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, 1CORT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.33 | ||
| Fwd PE | 27.05 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1CORT is valued a bit more expensive than the industry average as 72.55% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1CORT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 43.92 | ||
| EV/EBITDA | 64.17 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1CORT may justify a higher PE ratio.
1CORT's earnings are expected to grow with 70.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.76
PEG (5Y)6.52
EPS Next 2Y47.92%
EPS Next 3Y70.13%
5. Dividend
5.1 Amount
1CORT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1CORT (6/18/2025, 7:00:00 PM)
62.7
+62.7 (+Infinity%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners79.51%
Inst Owner ChangeN/A
Ins Owners6.55%
Ins Owner ChangeN/A
Market Cap6.65B
Revenue(TTM)685.45M
Net Income(TTM)133.99M
Analysts82
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.62%
Min EPS beat(2)-40.2%
Max EPS beat(2)16.96%
EPS beat(4)3
Avg EPS beat(4)13.93%
Min EPS beat(4)-40.2%
Max EPS beat(4)42.54%
EPS beat(8)7
Avg EPS beat(8)20.33%
EPS beat(12)9
Avg EPS beat(12)10.46%
EPS beat(16)12
Avg EPS beat(16)11.02%
Revenue beat(2)0
Avg Revenue beat(2)-11.81%
Min Revenue beat(2)-13.38%
Max Revenue beat(2)-10.25%
Revenue beat(4)2
Avg Revenue beat(4)-4.03%
Min Revenue beat(4)-13.38%
Max Revenue beat(4)4.07%
Revenue beat(8)6
Avg Revenue beat(8)-0.63%
Revenue beat(12)7
Avg Revenue beat(12)-1.42%
Revenue beat(16)8
Avg Revenue beat(16)-1.71%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.33 | ||
| Fwd PE | 27.05 | ||
| P/S | 11.35 | ||
| P/FCF | 43.92 | ||
| P/OCF | 43.37 | ||
| P/B | 11.39 | ||
| P/tB | 11.39 | ||
| EV/EBITDA | 64.17 |
EPS(TTM)0.99
EY1.58%
EPS(NY)2.32
Fwd EY3.7%
FCF(TTM)1.43
FCFY2.28%
OCF(TTM)1.45
OCFY2.31%
SpS5.52
BVpS5.51
TBVpS5.51
PEG (NY)4.76
PEG (5Y)6.52
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.83% | ||
| ROE | 19.61% | ||
| ROCE | 15.76% | ||
| ROIC | 13.61% | ||
| ROICexc | 25.27% | ||
| ROICexgc | 25.27% | ||
| OM | 16.17% | ||
| PM (TTM) | 19.55% | ||
| GM | 98.43% | ||
| FCFM | 25.85% |
ROA(3y)17.09%
ROA(5y)19.27%
ROE(3y)20.64%
ROE(5y)22.43%
ROIC(3y)17.94%
ROIC(5y)20.7%
ROICexc(3y)74.13%
ROICexc(5y)85.06%
ROICexgc(3y)74.13%
ROICexgc(5y)85.06%
ROCE(3y)20.79%
ROCE(5y)23.98%
ROICexgc growth 3Y-18.86%
ROICexgc growth 5Y-17.58%
ROICexc growth 3Y-18.86%
ROICexc growth 5Y-17.58%
OM growth 3Y-15.83%
OM growth 5Y-11.04%
PM growth 3Y-12.04%
PM growth 5Y-7.41%
GM growth 3Y-0.06%
GM growth 5Y0.04%
F-Score6
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 159.44% | ||
| Profit Quality | 132.22% | ||
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 31.21 |
F-Score6
WACC9.75%
ROIC/WACC1.4
Cap/Depr(3y)72.82%
Cap/Depr(5y)100.78%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.19%
Profit Quality(3y)125.51%
Profit Quality(5y)133.52%
High Growth Momentum
Growth
EPS 1Y (TTM)9.43%
EPS 3Y11.69%
EPS 5Y9.71%
EPS Q2Q%-32%
EPS Next Y13.31%
EPS Next 2Y47.92%
EPS Next 3Y70.13%
EPS Next 5Y56%
Revenue 1Y (TTM)30.93%
Revenue growth 3Y22.64%
Revenue growth 5Y17.11%
Sales Q2Q%7.09%
Revenue Next Year29.78%
Revenue Next 2Y32.48%
Revenue Next 3Y32.46%
Revenue Next 5Y30.41%
EBIT growth 1Y-9.1%
EBIT growth 3Y3.23%
EBIT growth 5Y4.18%
EBIT Next Year20.41%
EBIT Next 3Y47.8%
EBIT Next 5YN/A
FCF growth 1Y60.04%
FCF growth 3Y5.38%
FCF growth 5Y7.73%
OCF growth 1Y61.51%
OCF growth 3Y5.66%
OCF growth 5Y7.79%
CORCEPT THERAPEUTICS INC / 1CORT.MI FAQ
What is the fundamental rating for 1CORT stock?
ChartMill assigns a fundamental rating of 7 / 10 to 1CORT.MI.
What is the valuation status for 1CORT stock?
ChartMill assigns a valuation rating of 2 / 10 to CORCEPT THERAPEUTICS INC (1CORT.MI). This can be considered as Overvalued.
What is the profitability of 1CORT stock?
CORCEPT THERAPEUTICS INC (1CORT.MI) has a profitability rating of 7 / 10.
What is the valuation of CORCEPT THERAPEUTICS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for CORCEPT THERAPEUTICS INC (1CORT.MI) is 63.33 and the Price/Book (PB) ratio is 11.39.
What is the earnings growth outlook for CORCEPT THERAPEUTICS INC?
The Earnings per Share (EPS) of CORCEPT THERAPEUTICS INC (1CORT.MI) is expected to grow by 13.31% in the next year.